Febrile seizures: current concepts.
Approximately 2 to 5 per cent of all children experience seizures in association with their febrile illness. In a vast majority of instances, these seizures are of benign nature without any long-term adverse implications. A small percentage of these children develop recurrent febrile seizures and a still smaller percentage develop epilepsy. Several studies have attempted to identify those children who are at risk to develop either recurrences or subsequent epilepsy, while others have examined different modalities of management of children with febrile seizures. This review presents an overview of the problem based on the findings of these studies.
D000367:Age Factors; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002675:Child, Preschool; D004569:Electroencephalography; D004827:Epilepsy / Q000209:etiology*; D004833:Epilepsy, Temporal Lobe / Q000209:etiology; D006801:Humans; D007223:Infant; D007360:Intelligence; D009422:Nervous System Diseases / Q000150:complications; D012008:Recurrence; D012306:Risk; D012640:Seizures / Q000150:complications*; D003294:Seizures, Febrile / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D013129:Spinal Puncture
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants